(Q33384029)

English

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.

scientific article

Statements

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma. (English)
0 references
0 references
0 references
0 references
Axel Hauschild
Sanjiv S Agarwala
Peter Hersey
Stephan Grabbe
Rene Gonzalez
Christian Peschel
Claus Garbe
Steven O'Day
J Michael White
Chenghua Xia
Kiran Patel
John M Kirkwood
2823-2830

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit